PlainRecalls
FDA Drug Moderate Class II Terminated

KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540 mL Bags, NDC: 63323-712-15, and 2) 2,053 mL Bags, NDC: 63323-712-20.

Reported: June 10, 2015 Initiated: April 28, 2015 #D-1114-2015

Product Description

KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540 mL Bags, NDC: 63323-712-15, and 2) 2,053 mL Bags, NDC: 63323-712-20.

Reason for Recall

Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
5,488 Bags
Distribution
US; Nationwide, including Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540 mL Bags, NDC: 63323-712-15, and 2) 2,053 mL Bags, NDC: 63323-712-20.. Recalled by Fresenius Kabi USA, LLC. Units affected: 5,488 Bags.
Why was this product recalled?
Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids
Which agency issued this recall?
This recall was issued by the FDA Drug on June 10, 2015. Severity: Moderate. Recall number: D-1114-2015.